BioStem Technologies, Inc., Announces the Addition of Three Key Scientific Advisory Board Members
20 avr. 2021 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, Fl., April 20, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™
25 mars 2021 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit
15 mars 2021 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
24 déc. 2020 14h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Technologies, Inc. Announces Launch of AEON™
27 oct. 2020 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Oct. 27, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Life Sciences Signs Manufacturing Agreement for Amniotic Membrane Allograft Platform
11 août 2020 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020
22 juil. 2020 17h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 22, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Life Sciences Receives Accreditation by The American Association of Tissue Banks® (AATB®)
15 juil. 2020 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 15, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Technologies, Inc. Announces Submission of Applications for Q-Codes from the Centers for Medicare and Medicaid Services (CMS)
02 juil. 2020 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 02, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a leading life sciences company specializing in the development and commercialization of perinatal...
BioStem Life Sciences Announces Expansion; Contract Manufacturing Capabilities, and Research and Development Laboratory
13 mars 2020 09h30 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 13, 2020 (GLOBE NEWSWIRE) -- BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life...